Page 22 - ஆல்பர்ட் ஐன்ஸ்டீன் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researcher receives $2.5 million award to curb HIV infection among people who inject drugs International organizations and countries around the world are working to eliminate HIV/AIDS by 2030. To reach this goal, new approaches are needed particularly among difficult-to-reach groups such as people who inject drugs (PWID), who are 30 times more likely to contract HIV/AIDS compared with the general population. Matthew Akiyama, M.D., assistant professor of medicine at Albert Einstein College of Medicine and an internist at Montefiore Health System, is one of only two recipients of a one-year, $2.5 million HIV/AIDS Research Avenir Award from the National Institute on Drug Abuse (NIDA), which will fund his efforts to use advanced genetic epidemiological tools to curb infection among PWID. The NIDA award is part of the National Institute of Health s Director s Pioneer Awards program.

Matthew akiyamaEmily hendersonNational institute on drug abuseNational institute of healthAlbert einstein college of medicineMontefiore health systemResearch avenir awardAlbert einstein collegeAvenir awardNational instituteDrug abusePioneer awardsEast africaஎமிலி ஹென்டர்சன்தேசிய நிறுவனம் ஆன் மருந்துதேசிய நிறுவனம் ஆஃப் ஆரோக்கியம்